CH373384A - Process for the preparation of isoxazolidones - Google Patents
Process for the preparation of isoxazolidonesInfo
- Publication number
- CH373384A CH373384A CH5881658A CH5881658A CH373384A CH 373384 A CH373384 A CH 373384A CH 5881658 A CH5881658 A CH 5881658A CH 5881658 A CH5881658 A CH 5881658A CH 373384 A CH373384 A CH 373384A
- Authority
- CH
- Switzerland
- Prior art keywords
- isoxazolidones
- sub
- acid
- formula
- strong
- Prior art date
Links
- QXDOFVVNXBGLKK-UHFFFAOYSA-N 3-Isoxazolidinone Chemical class OC1=NOCC1 QXDOFVVNXBGLKK-UHFFFAOYSA-N 0.000 title claims description 12
- 238000000034 method Methods 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 239000002798 polar solvent Substances 0.000 claims description 4
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 239000006227 byproduct Substances 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- LQCNSMGLNLPUIE-UHFFFAOYSA-N ethyl aziridine-2-carboxylate Chemical compound CCOC(=O)C1CN1 LQCNSMGLNLPUIE-UHFFFAOYSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000203 mixture Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 2
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 229960003077 cycloserine Drugs 0.000 description 2
- -1 ethylene imine carboxylic acid ester Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical class C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940083618 sodium nitroprusside Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Description
Verfahren zur Herstellung von Isoxazolidonen Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von Isoxazolidonen der Formel
EMI0001.0004
worin Ri Wasserstoff oder eine Alkylgruppe be deutet, welches dadurch gekennzeichnet ist, dass man einen Äthylenimincarbonsäureester der Formel
EMI0001.0008
worin R, den Rest eines primären aliphatischen Al kohols bedeutet, mit starken Säuren in einem polaren Lösungsmittel behandelt,
danach das Reaktionspro dukt mit Hydroxylamin und einer starken Base in Gegenwart von Wasser behandelt und das erhaltene Isoxazolidon isoliert.
Das Ausgangsmaterial kann durch Einwirkung von flüssigem Ammoniak auf entsprechende a-brom- a,/3-ungesättigte Carbonsäureester hergestellt werden.
Die Behandlung von Äthyleniminverbindungen der Formel II mit starken Säuren liefert im allge meinen ein Gemisch von in a- bzw. in ss-Stellung den entsprechenden Säurerest tragenden ,B-Amino- und a-Aminosäureestersalzen, wobei in vielen Fällen die ss-Aminosäureestersalze mengenmässig vor herrschen. Nach dem erfindungsgemässen Verfahren werden jedoch vorwiegend die a-Aminoverbindungen gebildet.
Die Bildung von a-Aminosäureestersalzen in überwiegender Menge ist deshalb sehr erwünscht, weil sich nur diese Isomere in Isoxazolidone der For mel 1 überführen lassen. Als starke Säure eignet sich vorzugsweise eine Halogenwasserstoffsäure, wie z. B. Chlorwasserstoffsäure. Als polares Lösungsmittel ver wendet man am besten Wasser.
Es ist weiter zweckmässig, die Umsetzung bei Normaltemperatur oder darunter durchzuführen. Es hat sich gezeigt, dass das genannte Isomerengemisch nicht aufgetrennt werden muss, sondern vorteilhaft direkt der weiteren Umsetzung mit Hydroxylamin unterworfen wird. Die erfindungsgemäss erhaltenen Isoxazolidone lassen sich dann leicht von den übrigen Umsetzungsprodukten, die als Nebenpro dukte anfallen, abtrennen. Dies geschieht zweck mässig, indem man die erhaltenen Isoxazolidone in wässeriger Lösung durch Filtration bei pH 7,5-9 von den- ausgefallenen Nebenprodukten befreit.
Die Isoxazolidone können dann aus der klaren Lösung in an sich bekannter Weise gewonnen werden.
<I>Beispiel</I> 4,60g Äthylenimin-2-carbonsäureäthylester wer den zu 10 cm3 38o/oiger Salzsäure bei 0 C langsam und unter Rühren gegeben. Nach 15 Minuten Rühren bei 0 C wird das Gemisch in 20 cm3 Alkohol ge gossen und bei 30 C im Vakuum eingedampft. Der ölige Rückstand wird mehrmals in Alkohol gelöst und wieder zur Trockne gebracht. Man lässt den Rückstand über Nacht im Hochvakuum und in An wesenheit von fester Natronlauge stehen, wobei das Öl erstarrt. Ausbeute: 7,55 g. Nach den Ergebnissen der Cromwellschen Titration [J.
Am. Chem. Soe., <I>70</I> (1948), 1320] beträgt der Gehalt des Endproduktes an a-Chlor-,B-amino - propionsäureäthylester - hydro- chlorid 381/o und an a-Amino-ss-chlor-propionsäure- äthylester-hydrochlorid demnach 62%.
(Durchführung der Titration: 100 mg des Ge misches werden in 10 cm3 Aceton/Alkohol 1:1 gelöst, mit 0,6 ml 3n alkoholischer Salzsäure ver setzt und mit 16 ml 0,2n Kaliumjodidlösung in AcetonjAlkohol 1 : 1 über Nacht gekocht.
Die Ti- tration des freigesetzten Jodes erfolgt mit 0,03n Na- triumthiosulfatlösung. 1 cm3 dieser Lösung entspricht 2,82 mg a-Chlor - ss - amino-propionsäureäthylester- hydrochlorid.) 6,43g Natronlauge werden in 40 cm3 Wasser gelöst, unter Rühren bis -15 C gekühlt und mit 3,35 g feinem, gepulvertem Hydroxylamin-hydro- chlorid versetzt.
Die Temperatur steigt nun auf -10 C; es wird aber wieder auf -15 C abgekühlt. 7,52 g des erhaltenen Gemisches von a-Chlor- ss - amino - propionsäureäthylester - hydrochlorid und a-Amino-ss-chlor-propionsäureäthylester-hydrochlorid werden portionenweise während etwa 20 Minuten in die Lösung eingetragen, so dass die Temperatur zwischen -14 und -15 C bleibt.
Nach 30minutigem Weiterrühren bei -15 C wird noch 1 Stunde bei 0 C und 1 Stunde bei 30 C gerührt. Dann werden dem Reaktionsgemisch 21 cm3 1n Natronlauge zugegeben, und die klare Lösung wird im Vakuum bei 50 C bis zu einem Gewicht von 18 g eingeengt.
Der Rück stand wird mit 60 cm3 Methanol geschüttelt,. das Natriumchlorid abgenutscht, dieses dreimal mit je 10 cm3 warmem Methanol (50 C) nachgewaschen und das Filtrat auf -17 C abgekühlt. Es wird nun vorsichtig und unter Rühren mit Eisessig während etwa 30 Minuten neutralisiert. Schon bei pH 9 wird die Lösung trüb und bei pH 7,5 bildet sich ein Nie derschlag, der abgenutscht wird.
Er enthält kein Isoxazolidon (Nitroprussidnatrium-Reaktion negativ). Das Filtrat wird dann auf pH 6 eingestellt, wobei Cycloserin ausfällt (totaler Eisessigverbrauch 3,8 cm3). Man rührt noch 21/2 Stunden bei -17 C weiter und filtriert dann das Cycloserin ab, wäscht es mit 10 cm3 auf -17 C gekühltem Methanol und trocknet es im Vakuum bei 50 C.
Schmelzpunkt 131 C (Zer- setzung). Ausbeute: 1,38 g = 34% der Theorie; Reinheit 97,40/0; Reinausbeute: 33%.
Process for the preparation of isoxazolidones The present invention relates to a process for the preparation of isoxazolidones of the formula
EMI0001.0004
in which Ri is hydrogen or an alkyl group, which is characterized in that an ethylene imine carboxylic acid ester of the formula
EMI0001.0008
where R, the remainder of a primary aliphatic alcohol, treated with strong acids in a polar solvent,
then the reaction product treated with hydroxylamine and a strong base in the presence of water and the isoxazolidone obtained is isolated.
The starting material can be prepared by the action of liquid ammonia on corresponding α-bromo-α, / 3-unsaturated carboxylic acid esters.
The treatment of ethyleneimine compounds of the formula II with strong acids generally gives a mixture of B-amino and a-amino acid ester salts bearing the corresponding acid residue in a- or ß-position, the ß-amino acid ester salts in many cases in quantity to rule. However, the α-amino compounds are predominantly formed in the process according to the invention.
The formation of a-amino acid ester salts in a predominant amount is very desirable because only these isomers can be converted into isoxazolidones of the formula 1. The strong acid is preferably a hydrohalic acid, such as. B. hydrochloric acid. The best polar solvent is water.
It is also advantageous to carry out the reaction at normal temperature or below. It has been shown that the isomer mixture mentioned does not have to be separated, but is advantageously subjected directly to the further reaction with hydroxylamine. The isoxazolidones obtained according to the invention can then easily be separated off from the other reaction products which arise as byproducts. This is conveniently done by removing the precipitated by-products from the isoxazolidones obtained in aqueous solution by filtration at pH 7.5-9.
The isoxazolidones can then be obtained from the clear solution in a manner known per se.
<I> Example </I> 4.60 g of ethylenimine-2-carboxylic acid ethyl ester are added slowly and with stirring to 10 cm3 of 38% hydrochloric acid at 0 C. After stirring for 15 minutes at 0 ° C., the mixture is poured into 20 cm3 of alcohol and evaporated at 30 ° C. in vacuo. The oily residue is dissolved several times in alcohol and brought back to dryness. The residue is left to stand overnight in a high vacuum and in the presence of solid sodium hydroxide solution, the oil solidifying. Yield: 7.55 g. According to the results of Cromwell's titration [J.
At the. Chem. Soe., <I> 70 </I> (1948), 1320], the content of the end product of α-chloro, B-amino-propionic acid ethyl ester - hydrochloride 381 / o and of a-amino-ss- chloropropionic acid ethyl ester hydrochloride therefore 62%.
(Carrying out the titration: 100 mg of the mixture are dissolved in 10 cm3 of acetone / alcohol 1: 1, 0.6 ml of 3N alcoholic hydrochloric acid are added and the mixture is boiled overnight with 16 ml of 0.2N potassium iodide solution in acetone / alcohol 1: 1.
The released iodine is titrated with 0.03N sodium thiosulphate solution. 1 cm3 of this solution corresponds to 2.82 mg of a-chloro - ss - amino-propionic acid ethyl ester hydrochloride. 6.43 g of sodium hydroxide solution are dissolved in 40 cm3 of water, cooled to -15 ° C. with stirring and 3.35 g of fine, powdered hydroxylamine -hydrochloride added.
The temperature now rises to -10 C; but it is cooled down to -15 ° C again. 7.52 g of the resulting mixture of a-chloro-ss-amino-propionic acid ethyl ester-hydrochloride and a-amino-s-chloro-propionic acid ethyl ester hydrochloride are introduced into the solution in portions for about 20 minutes, so that the temperature between -14 and -15 C remains.
After stirring for a further 30 minutes at -15 ° C., stirring is continued for 1 hour at 0 ° C. and 1 hour at 30 ° C. Then 21 cm3 of 1N sodium hydroxide solution are added to the reaction mixture, and the clear solution is concentrated in vacuo at 50 ° C. to a weight of 18 g.
The residue is shaken with 60 cm3 of methanol. the sodium chloride is filtered off with suction, washed three times with 10 cm3 of warm methanol (50 ° C.) each time and the filtrate is cooled to -17 ° C. It is then carefully neutralized with glacial acetic acid for about 30 minutes while stirring. Even at pH 9, the solution becomes cloudy and at pH 7.5 a precipitate forms, which is sucked off.
It does not contain isoxazolidone (sodium nitroprusside reaction negative). The filtrate is then adjusted to pH 6, whereby cycloserine precipitates (total glacial acetic acid consumption 3.8 cm3). The mixture is stirred for a further 21/2 hours at -17 C and then the cycloserine is filtered off, washed with 10 cm3 of methanol cooled to -17 C and dried in vacuo at 50 C.
Melting point 131 C (decomposition). Yield: 1.38 g = 34% of theory; Purity 97.40 / 0; Pure yield: 33%.
Claims (1)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH5881658A CH373384A (en) | 1958-04-26 | 1958-04-26 | Process for the preparation of isoxazolidones |
BE577746A BE577746A (en) | 1958-04-26 | 1959-04-15 | Process for the preparation of isoxazolidone derivatives. |
ES0248991A ES248991A1 (en) | 1958-04-26 | 1959-04-25 | Procedure for the production of isoxazolidone compounds (Machine-translation by Google Translate, not legally binding) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH5881658A CH373384A (en) | 1958-04-26 | 1958-04-26 | Process for the preparation of isoxazolidones |
Publications (1)
Publication Number | Publication Date |
---|---|
CH373384A true CH373384A (en) | 1963-11-30 |
Family
ID=4521952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH5881658A CH373384A (en) | 1958-04-26 | 1958-04-26 | Process for the preparation of isoxazolidones |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE577746A (en) |
CH (1) | CH373384A (en) |
ES (1) | ES248991A1 (en) |
-
1958
- 1958-04-26 CH CH5881658A patent/CH373384A/en unknown
-
1959
- 1959-04-15 BE BE577746A patent/BE577746A/en unknown
- 1959-04-25 ES ES0248991A patent/ES248991A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE577746A (en) | 1959-10-15 |
ES248991A1 (en) | 1959-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH335520A (en) | Process for the preparation of N-alkyl-piperidine-monocarboxamides and N-alkyl-pyrrolidine-α-monocarboxamides | |
DE1238478B (en) | Process for the preparation of 3-amino-pyrazine-carboxylic acid derivatives | |
CH373384A (en) | Process for the preparation of isoxazolidones | |
DE1695136B2 (en) | Process for the preparation of 3-amino-5-methylisoxazole | |
DE1963991B2 (en) | Process for the preparation of a derivative of L-3,4-dihydroxyphenylalanine | |
AT209899B (en) | Process for the preparation of isoxazolidone compounds | |
CH376921A (en) | Process for the preparation of isoxazolidones | |
DE3408850C2 (en) | ||
AT216495B (en) | Process for the production of new phenylalanine derivatives and their salts | |
DE850297C (en) | Process for the preparation of amidine salts | |
AT235473B (en) | Process for the preparation of 7-dehydro-cholesterol esters | |
AT258910B (en) | Process for the preparation of benzo-dihydro-thiadiazine derivatives | |
AT205027B (en) | Process for the preparation of new α-aroyl-α-phthaliminoacetic acid esters | |
AT326638B (en) | PROCESS FOR THE PREPARATION OF N (BETA DIETYLAMINO ETHYL) -4-AMINO-5-CHLORO-2-METHOXYBENZAMIDE | |
DE702829C (en) | Process for the manufacture of pyridine caps | |
AT212982B (en) | Process for the separation of the optical antipodes of 3,5-diiodothyronine | |
AT218009B (en) | Process for the production of new phenylalanine derivatives and their salts | |
AT233010B (en) | Process for the preparation of new benzo-dihydro-1, 2, 4-thiadiazine-1, 1-dioxyden | |
AT252238B (en) | Process for the preparation of the D, L-4-amino-isoxazolidons-3 | |
AT216671B (en) | Process for the preparation of compounds of various penicillins with sulfonamides | |
AT283608B (en) | Process for the manufacture of new steroids | |
AT228793B (en) | Process for the preparation of new iminodibenzyl derivatives | |
AT201577B (en) | Process for the production of amino hydrochlorides or quaternary ammonium chlorides | |
AT215417B (en) | Process for the preparation of new N-carbalkoxy- or -aralkoxyalkyl-β- (3,4-dihydroxyphenyl) -β-hydroxyethylamines and their salts | |
DE2236005C3 (en) | Dibenzagonal bracket on d, square bracket for -dioxepin- square bracket for 1.3 square bracket for -derivatives and their pharmacologically acceptable salts, as well as processes for their production and pharmaceuticals containing them |